Skip to main content

Scientists Discover Way to Send Information into Black Holes Without Using Energy

3 comments

Breakthrough Discovery: Scientists Identify Key Protein Behind Rapid Spread of Deadly Breast Cancer

Triple-negative breast cancer (TNBC) is one of the most aggressive and difficult-to-treat forms of cancer. Unlike other breast cancers, it does not respond to common hormone therapies, making treatment options limited. While doctors have become better at removing tumors through surgery, the real danger begins when cancer spreads to other parts of the body—a process known as metastasis. This is often what makes TNBC life-threatening.

Now, researchers from Ben-Gurion University of the Negev have made an important discovery that could help explain why this cancer spreads so quickly—and how it might be stopped.

The Protein Driving Cancer Spread

The research team, led by Etta Livneh and Moshe Elkabets, identified a protein called PKC-eta as a major driver of cancer spread in TNBC.

Proteins are essential molecules in our body that control many cellular processes. However, in cancer, some proteins can become overactive and harmful. In this case, PKC-eta appears to act like a “switch” that turns on the cancer cells’ ability to move and invade other tissues.

The researchers found that PKC-eta plays several dangerous roles:

  • It increases the ability of cancer cells to move freely

  • It helps cells break away from the original tumor

  • It enables them to invade other organs such as the lungs and liver

In simple terms, PKC-eta gives cancer cells the power to travel and spread more efficiently.

How PKC-eta Works: The YAP Connection

The study also uncovered how PKC-eta carries out this function. It interacts with another important protein called YAP protein, which is part of the Hippo signaling pathway.

The Hippo pathway normally controls cell growth and prevents tumors from forming. But when YAP becomes overactive, it can promote cancer progression. PKC-eta binds to and activates YAP, effectively hijacking this pathway.

This interaction triggers a set of genes that:

  • Allow cancer cells to detach from the main tumor

  • Help them survive while traveling in the body

  • Support the formation of new tumors in distant organs

This explains why TNBC can spread so quickly compared to other types of cancer.

What Happens When PKC-eta Is Blocked?

To test whether PKC-eta is truly responsible for cancer spread, researchers conducted experiments using cancer cells and animal models.

The results were striking.

When PKC-eta activity was reduced or completely blocked:

  • Tumor growth slowed down significantly

  • Cancer cells lost their ability to spread effectively

  • Metastasis to vital organs was greatly reduced

These findings strongly suggest that PKC-eta is not just involved—but is a key driver of aggressive cancer behavior.

A Potential Game-Changer: Natural Peptide Therapy

Beyond identifying the problem, the researchers also discovered a potential solution.

They found a naturally occurring peptide—a small chain of amino acids—encoded within the genetic sequence related to PKC-eta. This peptide has a unique ability: it can target and break down the PKC-eta protein.

When this peptide was introduced in laboratory models:

  • PKC-eta levels dropped

  • YAP activity was disrupted

  • Cancer spread to organs like the lungs and liver was significantly reduced

This opens the door to a completely new type of treatment. Instead of broadly attacking cancer cells, this approach specifically targets the protein responsible for metastasis.

According to the researchers, this peptide could potentially be developed into a targeted drug for patients with aggressive breast cancer.

Why This Discovery Matters

Triple-negative breast cancer accounts for about 10–15% of all breast cancer cases, but it causes a disproportionately high number of deaths. Its aggressive nature and limited treatment options make it a major challenge in oncology.

This discovery is important for several reasons:

1. Early Detection of High-Risk Patients
High levels of PKC-eta were found in tumors associated with poor outcomes. This means the protein could serve as a biomarker to identify patients who are more likely to develop metastasis.

2. New Treatment Target
Targeting PKC-eta directly could slow or even prevent cancer spread, addressing the most dangerous aspect of the disease.

3. Precision Medicine Approach
The peptide therapy represents a more focused and potentially less toxic treatment compared to traditional chemotherapy.

Still Early, But Promising

While the findings are exciting, it is important to understand that this research is still in the experimental stage. The results come from laboratory studies and animal models, not yet from human clinical trials.

More research is needed to:

  • Confirm safety and effectiveness in humans

  • Develop drugs based on the peptide

  • Understand long-term outcomes

However, the strong link between PKC-eta and cancer spread makes this a promising direction for future therapies.

The Bigger Picture

Cancer research is increasingly focused on understanding the molecular mechanisms behind disease progression. Instead of treating cancer as a single condition, scientists are uncovering the specific pathways and proteins that drive each type.

This study is a perfect example of that shift. By identifying PKC-eta as a central player in metastasis, researchers are not only explaining why TNBC is so aggressive but also pointing toward a targeted way to fight it.

Conclusion

The discovery of PKC-eta’s role in triple-negative breast cancer marks a significant step forward in understanding one of the most dangerous forms of cancer. By uncovering how this protein activates pathways that enable cancer to spread, scientists have identified both a warning signal and a potential target for treatment.

Although more work is needed before this can benefit patients directly, the research offers real hope. If future studies confirm these findings, therapies targeting PKC-eta could one day slow down—or even stop—the spread of this aggressive disease.

In the fight against cancer, stopping metastasis is one of the biggest challenges. This breakthrough brings us one step closer to achieving that goal.

Reference: Vijayasteltar B. Liju et al, PKC-eta promotes breast cancer metastasis by regulating the Hippo–YAP signaling pathway, Signal Transduction and Targeted Therapy (2026). DOI: 10.1038/s41392-026-02572-0

Comments

Post a Comment

Popular

Scientists Discover Way to Send Information into Black Holes Without Using Energy

For years, scientists believed that adding even one qubit (a unit of quantum information) to a black hole needed energy. This was based on the idea that a black hole’s entropy must increase with more information, which means it must gain energy. But a new study by Jonah Kudler-Flam and Geoff Penington changes that thinking. They found that quantum information can be teleported into a black hole without adding energy or increasing entropy . This works through a process called black hole decoherence , where “soft” radiation — very low-energy signals — carry information into the black hole. In their method, the qubit enters the black hole while a new pair of entangled particles (like Hawking radiation) is created. This keeps the total information balanced, so there's no violation of the laws of physics. The energy cost only shows up when information is erased from the outside — these are called zerobits . According to Landauer’s principle, erasing information always needs energy. But ...
3 comments
Read more

Black Holes That Never Dies

Black holes are powerful objects in space with gravity so strong that nothing can escape them. In the 1970s, Stephen Hawking showed that black holes can slowly lose energy by giving off tiny particles. This process is called Hawking radiation . Over time, the black hole gets smaller and hotter, and in the end, it disappears completely. But new research by Menezes and his team shows something different. Using a theory called Loop Quantum Gravity (LQG) , they studied black holes with quantum corrections. In their model, the black hole does not vanish completely. Instead, it stops shrinking when it reaches a very small size. This leftover is called a black hole remnant . They also studied something called grey-body factors , which affect how much energy escapes from a black hole. Their findings show that the black hole cools down and stops losing mass once it reaches a minimum mass . This new model removes the idea of a “singularity” at the center of the black hole and gives us a better ...
Post a Comment
Read more

How Planetary Movements Might Explain Sunspot Cycles and Solar Phenomena

Sunspots, dark patches on the Sun's surface, follow a cycle of increasing and decreasing activity every 11 years. For years, scientists have relied on the dynamo model to explain this cycle. According to this model, the Sun's magnetic field is generated by the movement of plasma and the Sun's rotation. However, this model does not fully explain why the sunspot cycle is sometimes unpredictable. Lauri Jetsu, a researcher, has proposed a new approach. Jetsu’s analysis, using a method called the Discrete Chi-square Method (DCM), suggests that planetary movements, especially those of Earth, Jupiter, and Mercury, play a key role in driving the sunspot cycle. His theory focuses on Flux Transfer Events (FTEs), where the magnetic fields of these planets interact with the Sun’s magnetic field. These interactions could create the sunspots and explain other solar phenomena like the Sun’s magnetic polarity reversing every 11 years. The Sun, our closest star, has been a subject of scient...
Post a Comment
Read more